AVAX Technologies, Inc.
AVAX Technologies, Inc. AVXT Peers
See (AVXT) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AVXT | $0.00 | N/A | 6.9K | N/A | N/A | N/A |
| NONOF | $75.61 | +3.43% | 335.6B | 21.18 | $3.57 | +2.20% |
| CSLLY | $79.06 | -0.02% | 153.1B | 28.96 | $2.73 | +1.67% |
| CMXHF | $151.50 | -4.36% | 73.4B | 27.85 | $5.44 | +1.83% |
| UCBJY | $92.77 | -0.18% | 35.8B | 29.83 | $3.11 | +0.85% |
| ARGNF | $562.00 | N/A | 34.3B | 34.25 | $16.41 | N/A |
| UCBJF | $179.39 | N/A | 34.1B | 28.84 | $6.22 | +0.88% |
| ODTC | $22,005.00 | +29.44% | 24.1B | -0.08 | -$268,995.00 | N/A |
| IVBXF | $9.26 | -2.53% | 15.3B | -926.00 | -$0.01 | N/A |
| GNMSF | $218.13 | +2.89% | 13.4B | 12.80 | $17.04 | N/A |
Stock Comparison
AVXT vs NONOF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, NONOF has a market cap of 335.6B. Regarding current trading prices, AVXT is priced at $0.00, while NONOF trades at $75.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas NONOF's P/E ratio is 21.18. In terms of profitability, AVXT's ROE is -3.44%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, AVXT is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs CSLLY Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, CSLLY has a market cap of 153.1B. Regarding current trading prices, AVXT is priced at $0.00, while CSLLY trades at $79.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas CSLLY's P/E ratio is 28.96. In terms of profitability, AVXT's ROE is -3.44%, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, AVXT is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs CMXHF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, CMXHF has a market cap of 73.4B. Regarding current trading prices, AVXT is priced at $0.00, while CMXHF trades at $151.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas CMXHF's P/E ratio is 27.85. In terms of profitability, AVXT's ROE is -3.44%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, AVXT is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs UCBJY Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, UCBJY has a market cap of 35.8B. Regarding current trading prices, AVXT is priced at $0.00, while UCBJY trades at $92.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas UCBJY's P/E ratio is 29.83. In terms of profitability, AVXT's ROE is -3.44%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, AVXT is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs ARGNF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, ARGNF has a market cap of 34.3B. Regarding current trading prices, AVXT is priced at $0.00, while ARGNF trades at $562.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas ARGNF's P/E ratio is 34.25. In terms of profitability, AVXT's ROE is -3.44%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, AVXT is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs UCBJF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, UCBJF has a market cap of 34.1B. Regarding current trading prices, AVXT is priced at $0.00, while UCBJF trades at $179.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas UCBJF's P/E ratio is 28.84. In terms of profitability, AVXT's ROE is -3.44%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, AVXT is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs ODTC Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, AVXT is priced at $0.00, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas ODTC's P/E ratio is -0.08. In terms of profitability, AVXT's ROE is -3.44%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, AVXT is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs IVBXF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, IVBXF has a market cap of 15.3B. Regarding current trading prices, AVXT is priced at $0.00, while IVBXF trades at $9.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas IVBXF's P/E ratio is -926.00. In terms of profitability, AVXT's ROE is -3.44%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, AVXT is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs GNMSF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, GNMSF has a market cap of 13.4B. Regarding current trading prices, AVXT is priced at $0.00, while GNMSF trades at $218.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas GNMSF's P/E ratio is 12.80. In terms of profitability, AVXT's ROE is -3.44%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, AVXT is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs WXXWY Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, WXXWY has a market cap of 13.1B. Regarding current trading prices, AVXT is priced at $0.00, while WXXWY trades at $6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas WXXWY's P/E ratio is 29.23. In terms of profitability, AVXT's ROE is -3.44%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, AVXT is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs WXIBF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, WXIBF has a market cap of 13B. Regarding current trading prices, AVXT is priced at $0.00, while WXIBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas WXIBF's P/E ratio is 29.09. In terms of profitability, AVXT's ROE is -3.44%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, AVXT is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs SBMFF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, SBMFF has a market cap of 9.9B. Regarding current trading prices, AVXT is priced at $0.00, while SBMFF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas SBMFF's P/E ratio is 55.30. In terms of profitability, AVXT's ROE is -3.44%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, AVXT is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs SBHMY Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, SBHMY has a market cap of 8.5B. Regarding current trading prices, AVXT is priced at $0.00, while SBHMY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, AVXT's ROE is -3.44%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, AVXT is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs TLPPF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, TLPPF has a market cap of 5.8B. Regarding current trading prices, AVXT is priced at $0.00, while TLPPF trades at $17.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas TLPPF's P/E ratio is 190.67. In terms of profitability, AVXT's ROE is -3.44%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, AVXT is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs TRSBF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, TRSBF has a market cap of 5.2B. Regarding current trading prices, AVXT is priced at $0.00, while TRSBF trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas TRSBF's P/E ratio is 18.52. In terms of profitability, AVXT's ROE is -3.44%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, AVXT is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs ABCZF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, AVXT is priced at $0.00, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, AVXT's ROE is -3.44%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, AVXT is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs ZLDPF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, ZLDPF has a market cap of 5B. Regarding current trading prices, AVXT is priced at $0.00, while ZLDPF trades at $71.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas ZLDPF's P/E ratio is -26.73. In terms of profitability, AVXT's ROE is -3.44%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, AVXT is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs INCPF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, AVXT is priced at $0.00, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas INCPF's P/E ratio is -108.67. In terms of profitability, AVXT's ROE is -3.44%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, AVXT is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs AKBLF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, AKBLF has a market cap of 4.8B. Regarding current trading prices, AVXT is priced at $0.00, while AKBLF trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas AKBLF's P/E ratio is 33.36. In terms of profitability, AVXT's ROE is -3.44%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, AVXT is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs LABFF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, AVXT is priced at $0.00, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas LABFF's P/E ratio is 28.95. In terms of profitability, AVXT's ROE is -3.44%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, AVXT is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs CAMRF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, CAMRF has a market cap of 3.9B. Regarding current trading prices, AVXT is priced at $0.00, while CAMRF trades at $67.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas CAMRF's P/E ratio is 69.90. In terms of profitability, AVXT's ROE is -3.44%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, AVXT is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs GNNSF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, GNNSF has a market cap of 3.6B. Regarding current trading prices, AVXT is priced at $0.00, while GNNSF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas GNNSF's P/E ratio is -21.25. In terms of profitability, AVXT's ROE is -3.44%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, AVXT is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs REGMF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, REGMF has a market cap of 3.5B. Regarding current trading prices, AVXT is priced at $0.00, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas REGMF's P/E ratio is -13.32. In terms of profitability, AVXT's ROE is -3.44%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, AVXT is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs SHJBF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, SHJBF has a market cap of 3B. Regarding current trading prices, AVXT is priced at $0.00, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas SHJBF's P/E ratio is -10.94. In terms of profitability, AVXT's ROE is -3.44%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, AVXT is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs TKBIF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, AVXT is priced at $0.00, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, AVXT's ROE is -3.44%, compared to TKBIF's ROE of N/A. Regarding short-term risk, AVXT is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs MPSYF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, AVXT is priced at $0.00, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, AVXT's ROE is -3.44%, compared to MPSYF's ROE of +2.51%. Regarding short-term risk, AVXT is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs ASPHF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, ASPHF has a market cap of 2.2B. Regarding current trading prices, AVXT is priced at $0.00, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, AVXT's ROE is -3.44%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, AVXT is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs BVNKF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, BVNKF has a market cap of 2.1B. Regarding current trading prices, AVXT is priced at $0.00, while BVNKF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas BVNKF's P/E ratio is 10.74. In terms of profitability, AVXT's ROE is -3.44%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, AVXT is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs BVNRY Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, BVNRY has a market cap of 2.1B. Regarding current trading prices, AVXT is priced at $0.00, while BVNRY trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas BVNRY's P/E ratio is 10.78. In terms of profitability, AVXT's ROE is -3.44%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, AVXT is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs BTTAY Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, AVXT is priced at $0.00, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, AVXT's ROE is -3.44%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, AVXT is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs MEOBF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, MEOBF has a market cap of 1.8B. Regarding current trading prices, AVXT is priced at $0.00, while MEOBF trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas MEOBF's P/E ratio is -16.00. In terms of profitability, AVXT's ROE is -3.44%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, AVXT is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs PHMMF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, AVXT is priced at $0.00, while PHMMF trades at $103.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas PHMMF's P/E ratio is 79.70. In terms of profitability, AVXT's ROE is -3.44%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, AVXT is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs GLPGF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, GLPGF has a market cap of 1.8B. Regarding current trading prices, AVXT is priced at $0.00, while GLPGF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas GLPGF's P/E ratio is -8.87. In terms of profitability, AVXT's ROE is -3.44%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, AVXT is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs PPTDF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, PPTDF has a market cap of 1.7B. Regarding current trading prices, AVXT is priced at $0.00, while PPTDF trades at $13.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas PPTDF's P/E ratio is 17.13. In terms of profitability, AVXT's ROE is -3.44%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, AVXT is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs GENSF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, GENSF has a market cap of 1.7B. Regarding current trading prices, AVXT is priced at $0.00, while GENSF trades at $26.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas GENSF's P/E ratio is -295.53. In terms of profitability, AVXT's ROE is -3.44%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, AVXT is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs ONTTF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, ONTTF has a market cap of 1.7B. Regarding current trading prices, AVXT is priced at $0.00, while ONTTF trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas ONTTF's P/E ratio is -8.14. In terms of profitability, AVXT's ROE is -3.44%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, AVXT is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs BRCTF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, AVXT is priced at $0.00, while BRCTF trades at $18.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas BRCTF's P/E ratio is 17.68. In terms of profitability, AVXT's ROE is -3.44%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, AVXT is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs BIESF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, AVXT is priced at $0.00, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas BIESF's P/E ratio is -44.44. In terms of profitability, AVXT's ROE is -3.44%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, AVXT is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs CSBTF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, CSBTF has a market cap of 1.1B. Regarding current trading prices, AVXT is priced at $0.00, while CSBTF trades at $28.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas CSBTF's P/E ratio is -240.94. In terms of profitability, AVXT's ROE is -3.44%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, AVXT is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs NURPF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, AVXT is priced at $0.00, while NURPF trades at $8.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas NURPF's P/E ratio is 12.66. In terms of profitability, AVXT's ROE is -3.44%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, AVXT is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs SNBIF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, SNBIF has a market cap of 1.1B. Regarding current trading prices, AVXT is priced at $0.00, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, AVXT's ROE is -3.44%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, AVXT is more volatile compared to SNBIF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs ASCLF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, ASCLF has a market cap of 904M. Regarding current trading prices, AVXT is priced at $0.00, while ASCLF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas ASCLF's P/E ratio is -23.31. In terms of profitability, AVXT's ROE is -3.44%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, AVXT is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs PHGUF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, PHGUF has a market cap of 806.2M. Regarding current trading prices, AVXT is priced at $0.00, while PHGUF trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas PHGUF's P/E ratio is -59.25. In terms of profitability, AVXT's ROE is -3.44%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, AVXT is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs BPMUF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, BPMUF has a market cap of 708.1M. Regarding current trading prices, AVXT is priced at $0.00, while BPMUF trades at $57.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas BPMUF's P/E ratio is 8.15. In terms of profitability, AVXT's ROE is -3.44%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, AVXT is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs CSPHF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, CSPHF has a market cap of 703.1M. Regarding current trading prices, AVXT is priced at $0.00, while CSPHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas CSPHF's P/E ratio is -51.81. In terms of profitability, AVXT's ROE is -3.44%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, AVXT is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs SOLTF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, SOLTF has a market cap of 632.7M. Regarding current trading prices, AVXT is priced at $0.00, while SOLTF trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas SOLTF's P/E ratio is -38.89. In terms of profitability, AVXT's ROE is -3.44%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, AVXT is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs INRLF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, INRLF has a market cap of 552.7M. Regarding current trading prices, AVXT is priced at $0.00, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas INRLF's P/E ratio is -5.08. In terms of profitability, AVXT's ROE is -3.44%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, AVXT is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs IVEVF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, IVEVF has a market cap of 506.3M. Regarding current trading prices, AVXT is priced at $0.00, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, AVXT's ROE is -3.44%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, AVXT is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs CLTEF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, CLTEF has a market cap of 504.7M. Regarding current trading prices, AVXT is priced at $0.00, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, AVXT's ROE is -3.44%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, AVXT is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs VBIZF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, VBIZF has a market cap of 503.4M. Regarding current trading prices, AVXT is priced at $0.00, while VBIZF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas VBIZF's P/E ratio is 24.20. In terms of profitability, AVXT's ROE is -3.44%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, AVXT is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs CKDXF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, CKDXF has a market cap of 475.6M. Regarding current trading prices, AVXT is priced at $0.00, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, AVXT's ROE is -3.44%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, AVXT is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs AAVXF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, AAVXF has a market cap of 457.4M. Regarding current trading prices, AVXT is priced at $0.00, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas AAVXF's P/E ratio is -2.13. In terms of profitability, AVXT's ROE is -3.44%, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, AVXT is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs TBGNF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, AVXT is priced at $0.00, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, AVXT's ROE is -3.44%, compared to TBGNF's ROE of N/A. Regarding short-term risk, AVXT is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs CYDY Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, CYDY has a market cap of 422.7M. Regarding current trading prices, AVXT is priced at $0.00, while CYDY trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas CYDY's P/E ratio is -17.15. In terms of profitability, AVXT's ROE is -3.44%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, AVXT is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs IDRSF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, IDRSF has a market cap of 418M. Regarding current trading prices, AVXT is priced at $0.00, while IDRSF trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas IDRSF's P/E ratio is -1.13. In terms of profitability, AVXT's ROE is -3.44%, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, AVXT is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs HBMHF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, HBMHF has a market cap of 408M. Regarding current trading prices, AVXT is priced at $0.00, while HBMHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, AVXT's ROE is -3.44%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, AVXT is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs PTCHF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, PTCHF has a market cap of 403.5M. Regarding current trading prices, AVXT is priced at $0.00, while PTCHF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas PTCHF's P/E ratio is 8.00. In terms of profitability, AVXT's ROE is -3.44%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, AVXT is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs NWBO Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, NWBO has a market cap of 395M. Regarding current trading prices, AVXT is priced at $0.00, while NWBO trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas NWBO's P/E ratio is -4.57. In terms of profitability, AVXT's ROE is -3.44%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, AVXT is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs CLVLF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, CLVLF has a market cap of 367.4M. Regarding current trading prices, AVXT is priced at $0.00, while CLVLF trades at $7.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas CLVLF's P/E ratio is 14.66. In terms of profitability, AVXT's ROE is -3.44%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, AVXT is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs CLVLY Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, CLVLY has a market cap of 342.8M. Regarding current trading prices, AVXT is priced at $0.00, while CLVLY trades at $6.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas CLVLY's P/E ratio is 13.68. In terms of profitability, AVXT's ROE is -3.44%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, AVXT is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs HLOSF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, HLOSF has a market cap of 321.6M. Regarding current trading prices, AVXT is priced at $0.00, while HLOSF trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas HLOSF's P/E ratio is -9.91. In terms of profitability, AVXT's ROE is -3.44%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, AVXT is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs BXPHF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, BXPHF has a market cap of 313.7M. Regarding current trading prices, AVXT is priced at $0.00, while BXPHF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas BXPHF's P/E ratio is -16.00. In terms of profitability, AVXT's ROE is -3.44%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, AVXT is more volatile compared to BXPHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs BOVNF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, BOVNF has a market cap of 309.3M. Regarding current trading prices, AVXT is priced at $0.00, while BOVNF trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas BOVNF's P/E ratio is -8.55. In terms of profitability, AVXT's ROE is -3.44%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, AVXT is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs PBBIF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, AVXT is priced at $0.00, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, AVXT's ROE is -3.44%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, AVXT is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs PRRUF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, PRRUF has a market cap of 277.5M. Regarding current trading prices, AVXT is priced at $0.00, while PRRUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas PRRUF's P/E ratio is -9.50. In terms of profitability, AVXT's ROE is -3.44%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, AVXT is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs ORYZF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, AVXT is priced at $0.00, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, AVXT's ROE is -3.44%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, AVXT is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs BSEM Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, BSEM has a market cap of 232M. Regarding current trading prices, AVXT is priced at $0.00, while BSEM trades at $14.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas BSEM's P/E ratio is -24.91. In terms of profitability, AVXT's ROE is -3.44%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, AVXT is more volatile compared to BSEM. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs NWPHF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, AVXT is priced at $0.00, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas NWPHF's P/E ratio is N/A. In terms of profitability, AVXT's ROE is -3.44%, compared to NWPHF's ROE of N/A. Regarding short-term risk, AVXT is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs MDCLF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, MDCLF has a market cap of 230.7M. Regarding current trading prices, AVXT is priced at $0.00, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, AVXT's ROE is -3.44%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, AVXT is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs SLNCF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, SLNCF has a market cap of 225.3M. Regarding current trading prices, AVXT is priced at $0.00, while SLNCF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas SLNCF's P/E ratio is -3.12. In terms of profitability, AVXT's ROE is -3.44%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, AVXT is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs RAONF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, RAONF has a market cap of 212M. Regarding current trading prices, AVXT is priced at $0.00, while RAONF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas RAONF's P/E ratio is -20.33. In terms of profitability, AVXT's ROE is -3.44%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, AVXT is more volatile compared to RAONF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs FPHAF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, AVXT is priced at $0.00, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, AVXT's ROE is -3.44%, compared to FPHAF's ROE of N/A. Regarding short-term risk, AVXT is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs BRAXF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, BRAXF has a market cap of 207.1M. Regarding current trading prices, AVXT is priced at $0.00, while BRAXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas BRAXF's P/E ratio is -0.03. In terms of profitability, AVXT's ROE is -3.44%, compared to BRAXF's ROE of -2.49%. Regarding short-term risk, AVXT is more volatile compared to BRAXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs VSBC Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, AVXT is priced at $0.00, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas VSBC's P/E ratio is N/A. In terms of profitability, AVXT's ROE is -3.44%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, AVXT is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs FGHQF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, AVXT is priced at $0.00, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, AVXT's ROE is -3.44%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, AVXT is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs HNSBF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, HNSBF has a market cap of 203.4M. Regarding current trading prices, AVXT is priced at $0.00, while HNSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, AVXT's ROE is -3.44%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, AVXT is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs GNFTF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, GNFTF has a market cap of 176.3M. Regarding current trading prices, AVXT is priced at $0.00, while GNFTF trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, AVXT's ROE is -3.44%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, AVXT is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs SCNLF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, SCNLF has a market cap of 176M. Regarding current trading prices, AVXT is priced at $0.00, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, AVXT's ROE is -3.44%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, AVXT is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs NGENF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, NGENF has a market cap of 172.6M. Regarding current trading prices, AVXT is priced at $0.00, while NGENF trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas NGENF's P/E ratio is -7.69. In terms of profitability, AVXT's ROE is -3.44%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, AVXT is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs OPORF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, OPORF has a market cap of 164.9M. Regarding current trading prices, AVXT is priced at $0.00, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas OPORF's P/E ratio is 12.00. In terms of profitability, AVXT's ROE is -3.44%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, AVXT is more volatile compared to OPORF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs RECEF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, RECEF has a market cap of 157.2M. Regarding current trading prices, AVXT is priced at $0.00, while RECEF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas RECEF's P/E ratio is -10.00. In terms of profitability, AVXT's ROE is -3.44%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, AVXT is more volatile compared to RECEF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs MLLCF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, AVXT is priced at $0.00, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas MLLCF's P/E ratio is -2.03. In terms of profitability, AVXT's ROE is -3.44%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, AVXT is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs AVCTF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, AVCTF has a market cap of 153.8M. Regarding current trading prices, AVXT is priced at $0.00, while AVCTF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas AVCTF's P/E ratio is -3.34. In terms of profitability, AVXT's ROE is -3.44%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, AVXT is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs SPHDF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, SPHDF has a market cap of 142.7M. Regarding current trading prices, AVXT is priced at $0.00, while SPHDF trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas SPHDF's P/E ratio is -3.29. In terms of profitability, AVXT's ROE is -3.44%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, AVXT is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs BRIBF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, BRIBF has a market cap of 134.1M. Regarding current trading prices, AVXT is priced at $0.00, while BRIBF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, AVXT's ROE is -3.44%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, AVXT is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs IPHYF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, IPHYF has a market cap of 133.6M. Regarding current trading prices, AVXT is priced at $0.00, while IPHYF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas IPHYF's P/E ratio is -2.10. In terms of profitability, AVXT's ROE is -3.44%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, AVXT is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs AAPGV Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, AVXT is priced at $0.00, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas AAPGV's P/E ratio is N/A. In terms of profitability, AVXT's ROE is -3.44%, compared to AAPGV's ROE of N/A. Regarding short-term risk, AVXT is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs PRNAF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, PRNAF has a market cap of 126.9M. Regarding current trading prices, AVXT is priced at $0.00, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, AVXT's ROE is -3.44%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, AVXT is more volatile compared to PRNAF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs AMGXF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, AMGXF has a market cap of 126.7M. Regarding current trading prices, AVXT is priced at $0.00, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, AVXT's ROE is -3.44%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, AVXT is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs PSTTF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, AVXT is priced at $0.00, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, AVXT's ROE is -3.44%, compared to PSTTF's ROE of N/A. Regarding short-term risk, AVXT is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs EPRXF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, AVXT is priced at $0.00, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, AVXT's ROE is -3.44%, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, AVXT is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs ADOIF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, AVXT is priced at $0.00, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, AVXT's ROE is -3.44%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, AVXT is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs JWCTF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, JWCTF has a market cap of 101.3M. Regarding current trading prices, AVXT is priced at $0.00, while JWCTF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas JWCTF's P/E ratio is -1.25. In terms of profitability, AVXT's ROE is -3.44%, compared to JWCTF's ROE of -0.47%. Regarding short-term risk, AVXT is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs PBIGF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, PBIGF has a market cap of 100M. Regarding current trading prices, AVXT is priced at $0.00, while PBIGF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas PBIGF's P/E ratio is -8.56. In terms of profitability, AVXT's ROE is -3.44%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, AVXT is more volatile compared to PBIGF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs TRGNF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, TRGNF has a market cap of 92.4M. Regarding current trading prices, AVXT is priced at $0.00, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas TRGNF's P/E ratio is -2.12. In terms of profitability, AVXT's ROE is -3.44%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, AVXT is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs CMVLF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, CMVLF has a market cap of 90.1M. Regarding current trading prices, AVXT is priced at $0.00, while CMVLF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas CMVLF's P/E ratio is -1.87. In terms of profitability, AVXT's ROE is -3.44%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, AVXT is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs IUGNF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, IUGNF has a market cap of 89.6M. Regarding current trading prices, AVXT is priced at $0.00, while IUGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas IUGNF's P/E ratio is -1.20. In terms of profitability, AVXT's ROE is -3.44%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, AVXT is more volatile compared to IUGNF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs ACHFF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, ACHFF has a market cap of 88.3M. Regarding current trading prices, AVXT is priced at $0.00, while ACHFF trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas ACHFF's P/E ratio is -44.67. In terms of profitability, AVXT's ROE is -3.44%, compared to ACHFF's ROE of +0.56%. Regarding short-term risk, AVXT is more volatile compared to ACHFF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.
AVXT vs MCURF Comparison
AVXT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AVXT stands at 6.9K. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, AVXT is priced at $0.00, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AVXT currently has a P/E ratio of N/A, whereas MCURF's P/E ratio is -16.90. In terms of profitability, AVXT's ROE is -3.44%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, AVXT is more volatile compared to MCURF. This indicates potentially higher risk in terms of short-term price fluctuations for AVXT.